Showing 1031-1040 of 2531 results for "".
Dupixent, Juvéderm Vollure XC, Bavencio Approvals
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-dupixent-juv-derm-vollure-xc-bavencio-approvals/18698/The FDA has approved Regeneron's injectable Dupixent (dupilumab) to treat adults with moderate-to-severe eczema. It will be marketed by Regeneron and Sanofi Genzyme in the US. Allergan's Juvéderm Vollure XC has received FDA approval based on a pivotal clinical trial in which 59 percent of subjects sTreatment Considerations for Hyperpigmentation
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/treatment-considerations-for-hyperpigmentation/18830/Seemal R. Desai, MD and Marta I. Rendon, MD discuss their treatment protocols for hyperpigmentation—from prescriptions and cosmeceuticals to lasers and peels. Noting that hyperpigmentation is a chronic, life-long condition, they emphasize the importance of vehicle consideration in enhancing efficacyAtopic Dermatitis Journal Club: AD Guidelines May Represent a ‘Paradigm Shift’ in Care
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/atopic-derm-journal-club-ad-guidelines-may-represent-a-paradigm-shift-in-care/24075/In the first video of this series, Derek Chu, MD and Peter Lio, MD talk about new atopic dermatitis (AD) guidelines from the American Academy of Allergy, Asthma and Immunology Joint Task Force. These guidelines potentially represent a reshaping of the approach to AD care and understanding, according'Clean Beauty' in Dermatology: A Scoping Review
https://practicaldermatology.com/issues/july-2025/clean-beauty/36492/The emergence of “clean beauty” as a consumer label has become a notable marketing trend, developed in the absence of standardized regulatory definitions, and it has been associated with shifts in consumer behaviors on a global scale.How Health Care Worker Dissatisfaction is Fueling a New Trend in Health Care
https://practicaldermatology.com/topics/practice-management/how-health-care-worker-dissatisfaction-is-fueling-a-new-trend-in-health-care/23837/Despite strain, many health care workers are finding new opportunities.New in My Practice: Rx/New Products
https://practicaldermatology.com/columns/new-products/new-in-my-practice-rxnew-products-1/23636/Impetigo: An Unconventional Case Report
https://practicaldermatology.com/topics/rare-disease/impetigo-an-unconventional-case-report/26246/Mauri Hart, a medical student at the Oklahoma State University College of Osteopathic Medicine, takes a look at a unique case study, and tests the reader's knowledge of impetigo.New in My Practice: Cosmeceuticals
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-cosmeceuticals-3/23826/Clinical Conversations: The Data for JAK Inhibitors in AD
https://practicaldermatology.com/series/jak-inhibitors-in-practice/clinical-conversations-the-data-for-jak-inhibitors-in-ad/20105/JAK inhibitors represent a new therapeutic class for the treatment of atopic dermatitis. Find out what the data show about their efficacy and tolerability in a conversation between Brad Glick, DO and Raj Chovatiya, MD. Discover how these drugs can fit into the treatment plan and how these experts diUpdates from ASDS and ISHRS
https://practicaldermatology.com/series/dermwire-tv/-dermwiretv-updates-from-asds-and-ishrs/18217/The Annual meeting of the American Society for Dermatologic Surgery (ASDS) gathered experts in dermatologic surgery in Phoenix. Joel L. Cohen, MD and Shannon Humphrey, MD, who received the 2018 ASDS Award for Outstanding Service, discussed effective cosmetic consults. Diane Berson, MD addressed both